Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Augustyns, Koen" or (type any "bookEditor journalEditor issueEditor" and editor="Augustyn...

Add to list
- Journal Article
- A1
- open access
From PERK to RIPK1 : design, synthesis and evaluation of novel potent and selective necroptosis inhibitors

Camilla Scarpellini, Sophie Valembois, Kenneth Goossens, Mike Vadi (UGent) , Caroline Lanthier, Greta Klejborowska, Pieter Van der Veken, Hans De Winter, Mathieu Bertrand (UGent) and Koen Augustyns

(2023) FRONTIERS IN CHEMISTRY. 11.
Add to list
- Journal Article
- A1
- open access
Targeting ferroptosis protects against experimental (multi)organ dysfunction and death

Samya Van Coillie (UGent) , Emily Van San (UGent) , Ines Goetschalckx, Bartosz Wiernicki (UGent) , Banibrata Mukhopadhyay, Wulf Tonnus, Sze Men Choi (UGent) , Ria Roelandt (UGent) , Catalina Dumitrascu, Ludwig Lamberts, et al.

(2022) NATURE COMMUNICATIONS. 13(1).
Add to list
- Journal Article
- A1
- open access
In vitro and in situ activity-based labeling of fibroblast activation protein with UAMC1110-derived probes

Yentl Van Rymenant, Muhammet Tanc, Roos Van Elzen, An Bracke, Olivier De Wever (UGent) , Koen Augustyns, Anne-Marie Lambeir, Mark Kockx, Ingrid De Meester and Pieter Van Der Veken

(2021) FRONTIERS IN CHEMISTRY. 9.
Add to list
- Miscellaneous
Targeting ferroptosis protects against multiorgan dysfunction and death

Tom Vanden Berghe (UGent) , Samya Van Coillie (UGent) , Ines Goetschalckx, Bartosz Wiernicki (UGent) , Banibrata Mukhopadhyay, Wulf Tonnus, Emily Van San (UGent) , Sze Men Choi (UGent) , Ria Roelandt (UGent) , Catalina Dumitrascu, et al.

(2021)
Add to list
Inhibitors targeting RIPK1/RIPK3 : old and new drugs

Sofie Martens, Sam Hofmans, Wim Declercq (UGent) , Koen Augustyns and Peter Vandenabeele (UGent)

(2020) TRENDS IN PHARMACOLOGICAL SCIENCES. 41(3). p.209-224
Add to list
Caspase-3 probes for PET imaging of apoptotic tumor response to anticancer therapy

Filipe Elvas, Tom Vanden Berghe (UGent) , Yves Adriaenssens, Peter Vandenabeele (UGent) , Koen Augustyns, Steven Staelens, Sigrid Stroobants, Pieter Van der Veken and Leonie Wyffels

(2019) ORGANIC & BIOMOLECULAR CHEMISTRY. 17(19). p.4801-4824
Add to list
Synthesis and evaluation of novel benzotropolones as Atg4B inhibiting autophagy blockers

Muhammet Tanc, Matthias Cleenewerck, Ammar Kurdi, Ria Roelandt (UGent) , Wim Declercq (UGent) , Guido De Meyer, Koen Augustyns, Wim Martinet and Pieter Van der Veken

(2019) BIOORGANIC CHEMISTRY. 87. p.163-168
Add to list
- Journal Article
- A2
- open access
DPP8/DPP9 inhibition elicits canonical Nlrp1b inflammasome hallmarks in murine macrophages

Nathalia Moraes de Vasconcelos (UGent) , Gwendolyn Vliegen, Amanda Gonçalves (UGent) , Emilie De Hert, Rosa Martín-Pérez, Nina Van Opdenbosch (UGent) , Anvesh Jallapally, Ruth Geiss-Friedlander, Anne-Marie Lambeir, Koen Augustyns, et al.

(2019) LIFE SCIENCE ALLIANCE. 2(1).
Add to list
- Journal Article
- A1
- open access
RIPK1-dependent cell death : a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)

Sofie Martens, Vera Goossens (UGent) , Lars Devisscher, Sam Hofmans, Polien Claeys, Marnik Vuylsteke (UGent) , Nozomi Takahashi (UGent) , Koen Augustyns and Peter Vandenabeele (UGent)

(2018) CELL DEATH & DISEASE. 9.
Add to list
Discovery of novel, drug-like ferroptosis inhibitors with in vivo efficacy

Lars Devisscher, Samya Van Coillie (UGent) , Sam Hofmans, Dries Van Rompaey, Kenneth Goossens, Eline Meul (UGent) , Louis Maes, Hans De Winter, Pieter Van Der Veken, Peter Vandenabeele (UGent) , et al.

(2018) JOURNAL OF MEDICINAL CHEMISTRY. 61(22). p.10126-10140

Academic Bibliography

From PERK to RIPK1 : design, synthesis and evaluation of novel potent and selective necroptosis inhibitors

Targeting ferroptosis protects against experimental (multi)organ dysfunction and death

In vitro and in situ activity-based labeling of fibroblast activation protein with UAMC1110-derived probes

Targeting ferroptosis protects against multiorgan dysfunction and death

Inhibitors targeting RIPK1/RIPK3 : old and new drugs

Caspase-3 probes for PET imaging of apoptotic tumor response to anticancer therapy

Synthesis and evaluation of novel benzotropolones as Atg4B inhibiting autophagy blockers

DPP8/DPP9 inhibition elicits canonical Nlrp1b inflammasome hallmarks in murine macrophages

RIPK1-dependent cell death : a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)

Discovery of novel, drug-like ferroptosis inhibitors with in vivo efficacy

Contents

Support

Contact